Protein Kinase C alpha (PRKCA) CRISPR in HCC827 Phospho-proteomics
Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive HF
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)
SUBMITTER: 
Yusuf A. Hannun
PROVIDER: MSV000093612 | MassIVE | Fri Dec 08 12:55:00 GMT 2023
REPOSITORIES: MassIVE
Similar Datasets
Project description:Transcriptome profile was obtained from a set of human embryonic stem cell (hESCs) line (WA09: H9) with different passage numbers (P1: 40s, P2: 100s, P3: 200s, P4: 300s passage). Culture adaptation occurs in hESCs during repeated in vitro culture to acquire ‘survival advantage’ to be highly resistant to various stresses. In special, difference in gene expression profile of cell death or apoptotic gene signature was evident between P1/P2 and P3/P4 hESCs.
2018-09-04 | GSE119386 | GEO
Project description:TuBo cell line (E) was compared to passage 1 (P1), 2 (P2) and 3 (P3) mammospheres to detect specific transcription isoforms associated to cancer stem cell.
2013-11-30 | GSE21475 | GEO
Project description:We assessed how lack of ISG15 influences the levels of transcripts after IFNa stimulation. Expression data from ISG15 deficient patients (P1, P2, P3) and control (C1, C6, C16) hTert fibroblasts
2014-12-01 | GSE60359 | GEO
Project description:During repair phase after naphathalene injury 3 subsets of myeloid cells accumulate at the site of injury including P1 (monoyte), P2 (monocyte-derived macrophages and P3 (resident alternatively activated airway macrophages). ST2 receptor was found to be expressed by P2 and P3 subsets. To understand which biological processes in lung macrophages were regulated by ST2, myeloid cell subsets were flow-sorted from Naphthalene-treated WT and ST2-/- mice on d6 and their transcriptome analyzed using RNA-seq
2020-07-30 | GSE155359 | GEO
Project description:Human tumor cell lines are important tools in tumor biological studies, here the authors report the establishment and characterization of 7 new ccRCC stable cell lines with complete clinical data. Gene expression and methylation were profiled with microarrays between the new cells and those had a finite in vitro life span, and the results prompt that genes such as SLC34A2 and VHL play key roles in the continuous in vitro growth and development of ccRCC. In order to find out what genetic features are related to the successful establishment of stable cell lines, early stage cells of 5 stable cell lines (UT14(P2), UT16(P2), UT33a(P3), UT48(P2), UT56(P1) ), named as P group and 5 finite cell lines (UT13a(P3), UT27(P3), UT37(P2), UT41(P2), UT54(P3) ) which could not be cultured more than 10 generations named as N group were chosen to do gene expression chip. Features such as age, gender, tumor size and Fuhrman nuclear grading were matched in these two groups.
2017-11-04 | GSE89533 | GEO
Project description:Human tumor cell lines are important tools in tumor biological studies, here the authors report the establishment and characterization of 7 new ccRCC stable cell lines with complete clinical data. Gene expression and methylation were profiled with microarrays between the new cells and those had a finite in vitro life span, and the results prompt that genes such as SLC34A2 and VHL play key roles in the continuous in vitro growth and development of ccRCC. In order to find out what genetic features are related to the successful establishment of stable cell lines, early stage cells of 5 stable cell lines (UT14(P2), UT16(P2), UT33a(P3), UT48(P2), UT56(P1) ), named as P group and 5 finite cell lines (UT13a(P3), UT27(P3), UT37(P2), UT41(P2), UT54(P3) ) which could not be cultured more than 10 generations named as N group were chosen to do gene expression chip. Features such as age, gender, tumor size and Fuhrman nuclear grading were matched in these two groups.
2017-11-04 | GSE89648 | GEO
Project description:Acute Myeloid Leukemia (AML) is the most common and aggressive form of acute leukemia, with a 5-year survival rate of just 24%. Over a third of all AML patients harbor activating mutations in kinases, such as the receptor tyrosine kinases FLT3 and KIT. FLT3 and KIT mutations are associated with poor clinical outcomes and lower remission rates in response to standard-of-care chemotherapy. We have recently identified that the core kinase of the non-homologous end joining DNA repair pathway, DNA-PK, is activated downstream of FLT3; and targeting DNA-PK sensitized FLT3-mutant AML cells to standard-of-care therapies. Herein, we investigated DNA-PK as a possible therapeutic vulnerability in KIT mutant AML, using isogenic FDC-P1 myeloid progenitor cell lines transduced with an empty vector or oncogenic mutant KIT (V560G, D816V). Targeted quantitative phosphoproteomic profiling identified phosphorylation of DNA-PK at threonine 2599 in KIT mutant cells, indicative of DNA-PK activation. Accordingly, proliferation assays revealed that KIT mutant FDC-P1 cells were more sensitive to the DNA-PK inhibitors M3814 or NU7441, compared to empty vector controls. DNA-PK inhibition combined with inhibition of KIT signaling via using the kinase inhibitors dasatinib or ibrutinib, or the protein phosphatase 2A activators FTY720 or AAL(S), led to synergistic cell death. Discovery phosphoproteomic analysis of KIT-D816V cells revealed that dasatinib single-agent treatment inhibited ERK1 activity, and M3814 single-agent treatment inhibited Akt/mTOR activity. The combination of dasatinib and M3814 treatment inhibited both ERK/MAPK and Akt/mTOR activity, and induced synergistic inhibition of phosphorylation of transcription regulators including MYC and MYB. This study provides insight into the oncogenic pathways regulated by DNA-PK beyond its canonical role in DNA repair, and demonstrates that DNA-PK is a promising novel therapeutic target for KIT mutant cancers.
2023-01-26 | PXD030214 | panorama
Project description:Embryonic Stem Cells expressing the BirA biotin ligase (BirA) together with a biotinylable version of the full length GATA1 (bioG1) or the truncated GATA1s (bioG1s) transcription factor were differentiated into Embryoid Bodies for 6 days. kithiCD41+ cells were FACS-sorted and grown onto OP9 cells layer for 2 days in the presence of TPO. The kithiCD41lo (P1), kitloCD41lo (P2), kitloCD41hi (P3) and kit-CD41hi (P4) subpopulations were then FACS-sorted and analysed by RNA sequencing
2020-06-15 | E-MTAB-8968 | biostudies-arrayexpress
Project description:Candida albicans is an opportunistic pathogen and a commensal fungus of the mucosa from many healthy patients. Invasive candidiasis (IC) has high levels of morbidity and mortality that are attributed to some extent to the difficulty in its early diagnosis. Diverse and immunogenic proteins with roles such as virulence and immune evasion are secreted by this pathogen. Immunoproteomics is an important technique for the assessment of antibody reactivities to immunogenic proteins and our group previously developed an algorithm to predict the clinical outcome in IC patients. With the ultimate purpose of discovering new biomarkers of IC, immunoproteomics was applied for the analysis of the serological response to hyphal C. albicans extracellular proteins. Gel-free proteomic analysis was performed by LC-MS/MS for the detection of the secreted proteins and 301 proteins were identified. As expected, gene ontology analysis in cellular component showed enrichment in proteins from extracellular region, cell wall, cell surface, cell periphery and intracellular region. Importantly, 46.5% of the intracellular proteins identified were also annotated in extracellular region. Furthermore, from the extracellular proteins identified here, 44 proteins were previously found to be immunogenic against human sera. To carry out immunoproteomic analysis, secreted proteins were separated by two-dimensional gel electrophoresis, electroblotted onto nitrocellulose membranes, and tested by Western blotting with three distinct pools of human sera: P1 (12 IC patients), P2 (11 patients with Candida infection associated with catheters) and P3 (11 patients without IC). A higher reactivity pattern was observed in P1 and P2 in comparison with P3. So far, Glx3 was immunogenic to P1 and P2 but not to P3. Eno1, Pgk1 and Pra1 were found to be more immunoreactive to both P1 and P2 than to the P3. This approach will contribute to a better and faster diagnosis of this life-threatening fungal infection.
2021-07-05 | PXD013933 | Pride
Project description:TuBo cell line (E) was compared to passage 1 (P1), 2 (P2) and 3 (P3) mammospheres to detect specific transcription isoforms associated to cancer stem cell. TuBo cell line (E) was compared to passage 1 (P1), 2 (P2) and 3 (P3) mammospheres. Exon-level transcription profiling was done using Affimetrix GeneChip Exon 1.0 ST. Exon-level analysis is more complex than gene-level analysis. The number of probesets to be investigated is at least 10 times larger in number than gene-level probesets. Thus results, upon statistical analysis, are massively contaminated by type I statistical errors, i.e. false positive [Della Beffa et al. 2008]. Furthermore, exon-level probesets are based only on four probes, which makes exon-level signal summarization more noisy than gene-level, where signal summarization is based on the overall probes encompassed by all exons of a gene. To moderate these issues we have expanded the number of experimental replications: six for TuBo and passage 1 mammosphere, four for passage 3 mammosphere and three for passage 2 mammosphere. Furthermore, after data summarization with RMA and normalization with sketch quantile method, alternative splicing detection between epithelial and mammospheres passages, was assessed using MiDAS, a two way anova developed by Affymetrix for the detection of alternative splicing events. We considered suitable for further investigations the splicing events in common between the sets of exons detected as spliced in each of the following comparisons: E vs P1, E vs P2 and E vs P3.
2013-11-30 | E-GEOD-21475 | biostudies-arrayexpress